Asset
ORITAVANCIN DIPHOSPHATE
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (2)
| Application | Approved | Type | Applicant |
|---|---|---|---|
| NDA 214155 | 2021-03-12 | NDA | MELINTA THERAPEUTICS LLC |
| NDA 206334 | 2014-08-06 | NDA | MELINTA THERAPEUTICS LLC |
Marketed products (2)
- KIMYRSA
- ORBACTIV